Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, delivered an adjusted loss per share of 27 cents in fourth-quarter 2023, narrower than the year-ago loss of 35 cents per share. The adjusted loss per share was also narrower than the Zacks Consensus Estimate of a loss of 31 cents.The company’s GAAP loss per share was 31 cents in the quarter, narrower than the year-ago period’s loss of 37 cents.Full-year adjusted loss per share was $1.11, narrower than the loss of $1.38 per share at ...

For the quarter ended December 2023, Pacific Biosciences of California (PACB) reported revenue of $58.36 million, up 113.4% over the same period last year. EPS came in at -$0.27, compared to -$0.35 in the year-ago quarter.The reported revenue represents a surprise of +0.20% over the Zacks Consensus Estimate of $58.24 million. With the consensus EPS estimate being -$0.31, the EPS surprise was +12.90%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how t ...

Todd Friedman - Senior Director, Investor Relations Susan Kim - Chief Financial Officer Company Participants Christian Henry - President & Chief Executive Officer Conference Call Participants Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2023 Earnings Conference Call February 15, 2024 5:00 PM ET But I do think at the margin, some customers might benefit from more reagent rental type programs. And the implication of that would be that would be, you would likely have higher consumable revenues. And ...

Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 12.90%. A quarter ago, it was expected that this maker of genetic analysis technology would post a loss of $0.30 per share when it actually produced a loss of $0.27, delivering a surprise of 10%.Over the ...

ATLANTA, Feb. 13, 2024 /PRNewswire/ -- VOLO Events Agency (VOLO), a leading producer of experiential marketing and live events for global brands, has won the best Event Technology award at the BizBash 11th Annual Event Experience Awards. The award recognizes the outstanding use of technology to create an immersive and engaging event experience for PacBio (NASDAQ: PACB) a pioneering leader in the Biotechnology industry. The product launch at AEG's NOVO theater in Los Angeles announced two new genomic sequenc ...

Pacific Biosciences of California (PACB) , popularly known as PacBio, recently announced two new high throughput library preparation kits and workflows, namely, HiFi Prep Kit 96 and HiFi Plex Prep Kit 96, optimized for its Revio sequencing system.With these kits, PacBio is likely to offer customers automated, scalable, high-performance library preparation solutions with a 40% cost reduction and a 60% workflow time reduction.Price PerformanceFor the past six months, PACB’s shares have declined 46.1% against ...

New Library Preparation Solutions Offer Never Before Achieved Scale for the Revio™ Sequencing System MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced two new high throughput library preparation kits and workflows optimized for its Revio sequencing system. With these kits, PacBio takes another leap forward in the long-read market by offering customers automated, scalable, and high-performance lib ...

Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, recently announced PanDNA, a versatile Nanobind DNA extraction kit.With the addition of this new offering, the range of sample types appropriate for long-read sequencing is now greater and includes bacteria, cells, tissue, blood, plant nuclei, and insects.Price PerformanceFor the past six months, PACB’s shares have plunged 51.8% compared with the industry’s decline of 4.8%. The S&P 500 increased 5.8% in the same time frame.Image Sou ...

Existing HT CBB Kit Enables High-Throughput Extraction of HMW DNA Tailored for HiFi With an Updated Workflow for Animal Blood and Bacteria MENLO PARK, Calif., Jan. 15, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced PanDNA, a versatile Nanobind DNA extraction kit. This new offering expands the array of sample types suitable for long-read sequencing, including cells, bacteria, blood, tissue, plant nuclei, and insects. Nano ...

PALO ALTO, Calif., Jan. 11, 2024 /PRNewswire/ -- TurnCare, a leading medical technology and services company dedicated to advancing how hospitals manage high acuity patients, is proud to announce the addition of John F. Milligan, Ph.D., investor, innovator, and former CEO of Gilead, to its Board of Directors. Dr. Milligan, a seasoned industry veteran, played a pivotal role in growing Gilead from an early-stage private company into a multi-billion-dollar business with a global footprint. Dr. Milligan's contr ...